Prostate Cancer

"In-bore" MRI prostate biopsy is a safe preoperative clinical tool to exclude significant prostate cancer in symptomatic patients with benign prostatic obstruction before transurethral laser enucleation. January 20, 2020

Tumour innervation and neurosignalling in prostate cancer. January 20, 2020

The Panel of 12 Cell-Free MicroRNAs as Potential Biomarkers in Prostate Neoplasms. January 20, 2020

Understanding Prostate Cancer in Gay, Bisexual, and Other Men Who Have Sex with Men and Transgender Women: A Review of the Literature. January 20, 2020

Testosterone Therapy: What We Have Learned From Trials. January 20, 2020

Percent tumor volume vs American Joint Committee on Cancer staging system subclassification for predicting biochemical recurrence in patients with pathologic T2 prostate cancer. January 17, 2020

Real World Experience With Pembrolizumab in Recurrent or Advanced Prostate Cancer. January 17, 2020

Targeted and Systematic Prostate Biopsy in Biopsy-naive Men With Positive Multiparameter Magnetic Resonance Imaging Findings: A Meta-analysis. January 17, 2020

METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer. January 17, 2020

Positive prostate biopsy following radiotherapy can predict metastasis-free survival in localized prostate cancer. January 17, 2020

How We Can Solve the Increase in Prostate Cancer Deaths? January 16, 2020

The Role of Radical Prostatectomy and Lymph Node Dissection in Clinically Node Positive Patients. January 16, 2020

Impact of biparametric prebiopsy prostate magnetic resonance imaging on the diagnostics of clinically significant prostate cancer in biopsy naïve men. January 16, 2020

Therapies Targeted to Androgen Receptor Signaling Axis in Prostate Cancer: Progress, Challenges, and Hope. January 16, 2020

Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer. January 16, 2020

The role of gadolinium in magnetic resonance imaging for early prostate cancer diagnosis: A diagnostic accuracy study. January 16, 2020

Clovis Oncology’s Rubraca® (rucaparib) Granted FDA Priority Review for Advanced Prostate Cancer January 15, 2020

Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy: a retrospective multicenter study in Japan. January 15, 2020

Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study). January 15, 2020

Diet and Lifestyle in Prostate Cancer. January 15, 2020

Page 1 of 1046